Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

Fact Sheet API

Bill Number

HRES 484

Introduced

Jun 17, 2021

Latest Action

Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

Sponsor

Cosponsors

Topics

Cardiovascular and respiratory health Commerce Competitiveness, trade promotion, trade deficits Emergency medical services and trauma care Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases Intellectual property Manufacturing

Full Text

View Full Bill Text

Votes

Summary

This resolution expresses the sense of the House of Representatives that the United States should not waive intellectual property protections for COVID-19 vaccines, treatments, or other related innovations.

Actions

Nov 1, 2022

Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Jun 17, 2021

Referred to the House Committee on the Judiciary.
Jun 17, 2021

Introduced in House

Amendments

Related Bills